Assignee
BOLD THERAPEUTICS INC
CA6 patents
Top patents by PatentIndex Score
US11040993B2Jun 22, 2021
Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
BOLD THERAPEUTICS INC4 citations82
US10611787B2Apr 7, 2020
Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
BOLD THERAPEUTICS INC4 citations82
US11739111B2Aug 29, 2023
Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
BOLD THERAPEUTICS INC2 citations71
US12415825B2Sep 16, 2025
Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
BOLD THERAPEUTICS INC0 citations61
US10821095B2Nov 3, 2020
Use of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] for the treatment of cancer
BOLD THERAPEUTICS INC4 citations61
US11633380B2Apr 25, 2023
Use of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] for the treatment of cancer
BOLD THERAPEUTICS INC0 citations50